Access to addiction meds for young people has improved — but retention hasn’t
Access to addiction meds for young people has improved — but retention hasn’t
News Archive
Browse all past biotechnology intelligence, clinical developments, and industry updates.
Archived Updates
Adecto blames ‘risk-adverse funding environment’ for closing
Adecto blames ‘risk-adverse funding environment’ for closing
An Ebola treatment center was burned down as the death toll in Congo passes 4,000
An Ebola treatment center was burned down as the death toll in Congo passes 4,000
Bayer doubles down on US with $2.2B Ohio manufacturing project
Bayer doubles down on US with $2.2B Ohio manufacturing project
Bayer taps new chief medical officer—Chutes & Ladders
Bayer taps new chief medical officer—Chutes & Ladders
Biogen's experimental lupus drug shows benefit against skin symptoms
Biogen's experimental lupus drug showed benefit against skin symptoms, according to the report.
BMO most bullish on Merck’s, bearish on BMS’ plans to contend with patent cliffs
BMO most bullish on Merck’s, bearish on BMS’ plans to contend with patent cliffs
Buzzy AI biotech Xaira unveils antibody platform ambitions
Buzzy AI biotech Xaira unveils antibody platform ambitions
Emboline Announces First U.S. Commercial Use of the Emboliner® Embolic Protection System
/PRNewswire/ -- Emboline, Inc., a medical technology company developing next-generation embolic protection technology, today announced the first commercial use...
Everlywell rolls out Clairity AI for breast cancer in US
Everlywell rolls out Clairity AI for breast cancer in US
Lilly’s BTK drug Jaypirca enters first-line CLL
Lilly’s BTK drug Jaypirca enters first-line CLL
Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved an additional indication for...
Locking in on pharma’s consumerization trend
Locking in on pharma’s consumerization trend
New diabetes and obesity studies making waves at EASD
New diabetes and obesity studies making waves at EASD
NIH rolling out streamlined website to help public find information more easily
NIH rolling out streamlined website to help public find information more easily